title: Hemodynamic assessment of pulmonary hypertension.
abstract: There has been significant progress in our understanding of the pathobiology, epidemiology and prognosis of pulmonary vascular disease and, over the past few years, there has been an explosion of clinical therapeutic trials for pulmonary arterial hypertension (PAH). The increasing number of different conditions now associated with PAH and the appearance of new diagnostic techniques have led to a need for a systematic diagnostic approaches and a new disease classification, which has resulted in notable improvements in the quality and efficacy of clinical care. We appreciate traditional resting right heart catheterization techniques (which still remain the gold standard for diagnosing PAH and managing patients on therapy) and look forward to novel invasive techniques (e.g. intravascular ultrasound) that add greatly to our understanding of right ventricle and pulmonary circulation, and for the interpretation of data from clinical trials as well.
authors.affiliation: Juan C Grignola, Department of Pathophysiology, Hospital de Clínicas, Facultad de Medicina, Universidad de la República, PC 11600, Montevideo, Uruguay.
authors.forename: Juan C
authors.initials: JC
authors.lastname: Grignola